Trademark Overview
On Wednesday, December 11, 2024, a trademark application was filed for TRUSESFLU with the United States Patent and Trademark Office. The USPTO has given the TRUSESFLU trademark a serial number of 98896126. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, December 11, 2024. This trademark is owned by GlaxoSmithKline Biologicals SA. The TRUSESFLU trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders